与萨菲纳胺和抗抑郁药物的同时治疗:来自实际临床实践的安全数据
P Pérez-Torre1, J L López-Sendón1, V Mañanes Barral2
1Movement Disorders Unit, Neurology Department, Ramón y Cajal Hospital, Madrid, Spain.
Neurologia
|April 14, 2024
概括
这项研究发现,在帕金森病患者中,将萨菲纳米德与抗抑郁药物结合使用并没有导致血清醇综合征. 现实世界的数据表明,这种组合是安全的,并且长期耐受良好.
科学领域:
- 神经药理学神经药理学
- 运动障碍 运动障碍
- 临床药理学 临床药理学
背景情况:
- 沙菲纳胺是一种用于治疗帕金森病的药物.
- 抗抑郁药通常被处方给帕金森病患者.
- 潜在的药物相互作用,包括血清素综合征,是令人担忧的.
研究的目的:
- 评估在帕金森病 (PD) 患者中与抗抑郁药同时使用沙菲纳胺的安全性.
- 评估在联合治疗的患者中血清激素综合征的发生率.
- 为了分析这种药物组合的真实世界临床数据.
主要方法:
- 追溯观察性研究设计.
- 包括帕金森病患者接受沙菲纳胺和任何抗抑郁药的治疗.
- 查血清激素综合征的症状,并收集同时服用药物的数据.
主要成果:
- 分析了服用萨菲纳的78名PD患者;25名 (32.05%) 也接受了抗抑郁药.
- 塞特拉林和埃斯基塔洛普拉姆是最常见的联合处方抗抑郁药.
- 在研究期间没有观察到血清素综合征或其典型表现的病例.
结论:
- 在PD患者中,萨菲纳胺和抗抑郁药的同时使用似乎是安全的,在临床实践中耐受良好.
- 长期同时使用并没有导致血清素综合征.
- 尽管观察到安全性,但建议进行个性化治疗和对不良反应的监测.
更多相关视频
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Antidepressant Drugs: Overview
466
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
466
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
134
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
380
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
380
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830


